Otis Worldwide Corp (OTIS) Stock Price Today
Aura AI Summary
Key Stats
- $27.21BMarket Cap
- -Volume
- IndustrialsSector
- $93.6252W High
- $69.3452W Low
- -Typical Hold Time
- $35.25BEnterprise Value
- 2.46%Div Yield
- -Trading Activity
Track Otis Worldwide Corp (OTIS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Otis Worldwide Corp has traded between a low of $69.34 and a high of $93.62, highlighting its annual price range. Buy and sell Otis Worldwide Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Otis Worldwide Corp
Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Most Recent News
Nvidia now holds a bigger share in S&P 500 funds than Apple, marking a major shift in investor preference.
Nvidia has surpassed Apple in the holdings of every S&P 500 index fund, reflecting a significant change in investment trends within these funds. This shift highlights growing investor confidence in Nvidia's growth potential and the tech sector's evol...
Hammond Power Solutions rated buy on growth from capacity expansion and AEG acquisition.
Hammond Power Solutions is rated a buy due to its expanded production capacity, strong demand from data centers, and the strategic acquisition of AEG. The company is positioned as a platform player with forecasted 2027 revenue of C$1.7 billion and ad...
TG Therapeutics shares rise on buyout rumors with potential 45-50% acquisition premium.
Shares of TG Therapeutics increased following rumors that a larger biopharma company with a market cap between $20-40 billion is considering acquiring TG. The company's growth, especially from its drug Briumvi and recent advances in formulation, make...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.